Melanoma | hsa05218 | 6.56 |
Platelet activation | hsa04611 | 5.66 |
Fc gamma R-mediated phagocytosis | hsa04666 | 6.21 |
Small cell lung cancer | hsa05222 | 6.17 |
cGMP-PKG signaling pathway | hsa04022 | 5.32 |
Natural killer cell mediated cytotoxicity | hsa04650 | 5.53 |
Colorectal cancer | hsa05210 | 6.52 |
Renal cell carcinoma | hsa05211 | 6.6 |
Jak-STAT signaling pathway | hsa04630 | 5.44 |
Signaling pathways regulating pluripotency of stem cells | hsa04550 | 5.6 |
cAMP signaling pathway | hsa04024 | 5.05 |
Prostate cancer | hsa05215 | 6.11 |
Leukocyte transendothelial migration | hsa04670 | 5.74 |
Cholinergic synapse | hsa04725 | 5.88 |
Choline metabolism in cancer | hsa05231 | 6.09 |
FoxO signaling pathway | hsa04068 | 5.63 |
Osteoclast differentiation | hsa04380 | 5.64 |
HIF-1 signaling pathway | hsa04066 | 5.9 |
Chemokine signaling pathway | hsa04062 | 5.19 |
Oxytocin signaling pathway | hsa04921 | 5.4 |
Aldosterone-regulated sodium reabsorption | hsa04960 | 7.41 |
VEGF signaling pathway | hsa04370 | 6.77 |
Focal adhesion | hsa04510 | 4.92 |
Endometrial cancer | hsa05213 | 6.81 |
Type II diabetes mellitus | hsa04930 | 7.12 |
Progesterone-mediated oocyte maturation | hsa04914 | 6.18 |
Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
Pancreatic cancer | hsa05212 | 6.56 |
Amoebiasis | hsa05146 | 5.82 |
Epstein-Barr virus infection | hsa05169 | 4.97 |
Toxoplasmosis | hsa05145 | 5.71 |
Influenza A | hsa05164 | 5.21 |
Apoptosis | hsa04210 | 6.23 |
HTLV-I infection | hsa05166 | 4.59 |
PI3K-Akt signaling pathway | hsa04151 | 4.21 |
Hepatitis C | hsa05160 | 5.68 |
Hepatitis B | hsa05161 | 5.52 |
Measles | hsa05162 | 5.6 |
B cell receptor signaling pathway | hsa04662 | 6.52 |
Chronic myeloid leukemia | hsa05220 | 6.48 |
Bacterial invasion of epithelial cells | hsa05100 | 6.34 |
Proteoglycans in cancer | hsa05205 | 5.02 |
Toll-like receptor signaling pathway | hsa04620 | 6.0 |
Pathways in cancer | hsa05200 | 3.98 |
Viral carcinogenesis | hsa05203 | 5.08 |
T cell receptor signaling pathway | hsa04660 | 6.01 |
Phosphatidylinositol signaling system | hsa04070 | 6.38 |
Rap1 signaling pathway | hsa04015 | 4.97 |
Ras signaling pathway | hsa04014 | 4.9 |
Inflammatory mediator regulation of TRP channels | hsa04750 | 6.07 |
Prolactin signaling pathway | hsa04917 | 6.6 |
Acute myeloid leukemia | hsa05221 | 6.74 |
Estrogen signaling pathway | hsa04915 | 6.11 |
TNF signaling pathway | hsa04668 | 5.96 |
Thyroid hormone signaling pathway | hsa04919 | 5.82 |
AMPK signaling pathway | hsa04152 | 5.8 |
mTOR signaling pathway | hsa04150 | 6.72 |
Regulation of actin cytoskeleton | hsa04810 | 4.9 |
Carbohydrate digestion and absorption | hsa04973 | 7.28 |
Non-small cell lung cancer | hsa05223 | 6.88 |
Insulin signaling pathway | hsa04910 | 5.55 |
Neurotrophin signaling pathway | hsa04722 | 5.78 |
Non-alcoholic fatty liver disease (NAFLD) | hsa04932 | 5.51 |
Central carbon metabolism in cancer | hsa05230 | 6.7 |
Glioma | hsa05214 | 6.66 |
Fc epsilon RI signaling pathway | hsa04664 | 6.6 |
Adrenergic signaling in cardiomyocytes | hsa04261 | 5.44 |
ErbB signaling pathway | hsa04012 | 6.15 |